Orthofix Medical Inc.Orthofix Medical Inc.Orthofix Medical Inc.

Orthofix Medical Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪721.10 M‬USD
−3.14USD
‪−151.40 M‬USD
‪746.64 M‬USD
‪36.88 M‬
Beta (1Y)
1.34
Employees (FY)
‪1.63 K‬
Change (1Y)
+542 +49.63%
Revenue / Employee (1Y)
‪456.94 K‬USD
Net income / Employee (1Y)
‪−92.65 K‬USD

About Orthofix Medical Inc.


CEO
Massimo Calafiore
Headquarters
Lewisville
Founded
1987
FIGI
BBG000G1C210
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of OFIX is 18.62 USD — it has increased by 0.75% in the past 24 hours. Watch Orthofix Medical Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Orthofix Medical Inc. stocks are traded under the ticker OFIX.
OFIX stock has fallen by −3.03% compared to the previous week, the month change is a 17.57% rise, over the last year Orthofix Medical Inc. has showed a 64.64% increase.
We've gathered analysts' opinions on Orthofix Medical Inc. future price: according to them, OFIX price has a max estimate of 27.20 USD and a min estimate of 22.00 USD. Watch OFIX chart and read a more detailed Orthofix Medical Inc. stock forecast: see what analysts think of Orthofix Medical Inc. and suggest that you do with its stocks.
OFIX reached its all-time high on Feb 26, 2019 with the price of 74.44 USD, and its all-time low was 5.63 USD and was reached on Jan 26, 1996. View more price dynamics on OFIX chart.
See other stocks reaching their highest and lowest prices.
OFIX stock is 2.53% volatile and has beta coefficient of 1.34. Track Orthofix Medical Inc. stock price on the chart and check out the list of the most volatile stocks — is Orthofix Medical Inc. there?
Today Orthofix Medical Inc. has the market capitalization of ‪721.10 M‬, it has increased by 7.22% over the last week.
Yes, you can track Orthofix Medical Inc. financials in yearly and quarterly reports right on TradingView.
Orthofix Medical Inc. is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
OFIX earnings for the last quarter are −0.71 USD per share, whereas the estimation was −0.34 USD resulting in a −105.80% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Orthofix Medical Inc. earnings.
Orthofix Medical Inc. revenue for the last quarter amounts to ‪196.61 M‬ USD, despite the estimated figure of ‪196.52 M‬ USD. In the next quarter, revenue is expected to reach ‪212.83 M‬ USD.
OFIX net income for the last quarter is ‪−27.39 M‬ USD, while the quarter before that showed ‪−33.44 M‬ USD of net income which accounts for 18.11% change. Track more Orthofix Medical Inc. financial stats to get the full picture.
No, OFIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪1.63 K‬ employees. See our rating of the largest employees — is Orthofix Medical Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Orthofix Medical Inc. EBITDA is ‪−27.56 M‬ USD, and current EBITDA margin is −11.88%. See more stats in Orthofix Medical Inc. financial statements.
Like other stocks, OFIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Orthofix Medical Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Orthofix Medical Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Orthofix Medical Inc. stock shows the buy signal. See more of Orthofix Medical Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.